Study of Ixekizumab in Healthy Participants

Exclusion Criteria

• •Have a significant history of, or current, cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, or hematologic disorders that in the opinion of the investigator poses an unacceptable risk to the participant if participating in the study
• •Are allergic or hypersensitive to the study medicine
• •Have dullness or loss of sensitivity on either side of your abdomen
• •Have any condition that could affect pain perception from an injection
• •Had a vaccination with a live vaccine within 12 months prior to the first check-in or intend to get a vaccine for tuberculosis within 12 months of completing treatment on this study
• •Have any type of hepatitis, human immunodeficiency virus (HIV) infection, or other serious infection
• •Show evidence of active or latent tuberculosis (TB)
• •Presence of significant neuropsychiatric disorder or a recent history of depression
• •Have excessive tattoos or scars over the abdomen or other factors such as rash or excessive folds of skin that would interfere with injection site assessments
• •Have had any active or recent infection within 4 weeks of Day 1 that, in the opinion of the investigator would pose an unacceptable risk to the participant if participating in the study